article thumbnail

As resistant tuberculosis rises, GSK says trial backs novel antibiotic

pharmaphorum

Cases of drug-resistant TB (DR-TB) rose 3% in 2021 over the previous year, the first increase since record-keeping started in 2004, according to the WHO report, which called for countries to move quickly to restore access to essential services to treat the disease, as well as greater investment in new vaccines and therapeutics.

article thumbnail

New Prescription Migraine Drugs Aren’t Resonating with Patients—Here’s How Pharma Can Boost Uptake

PM360

Among surveyed patients, nearly half (47%) couldn’t remember a single preventive migraine brand name, and the leading brand patients did recall— Topamax —is an older drug that was approved for migraine in 2004. Other influencing factors included more information on side effects (36%), drug cost (28%), and efficacy (28%).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novel oral chemotherapeutic holds potential for stomach cancer patients

European Pharmaceutical Review

There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer.

Patients 104
article thumbnail

Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?

Clarivate

A ‘magic bullet’ medicine that can cure a disease quickly and completely, [1] without deleterious side effects. [2] 6] As many pathogenetic targets have multiple physiological functions, highly specific ‘magic bullets’ may impact multiple cellular pathways simultaneously, causing unintended side effects.7

article thumbnail

PROTACs show promise for cancer treatment

Pharmaceutical Technology

By selectively degrading these proteins, PROTACs have the potential to effectively treat a range of diseases with potentially fewer side effects compared to traditional approaches.

article thumbnail

How A Former Healthcare professional Is Changing Medical Sales With Jaclene Corstorphine

Evolve Your Success

03:29 this was circa 2004, 2005 it was a you know a new kind of career path that was available. These side effects are obviously not super attractive to men, so this is a focal therapy. It was really hot at that time and everybody wanted Wait, wait, wait, wait. 03:22 – Samuel Adeyinka (Host) So why was it hot?

article thumbnail

How A Former Healthcare professional Is Changing Medical Sales With Jaclene Corstorphine

Evolve Your Success

03:29 this was circa 2004, 2005 it was a you know a new kind of career path that was available. These side effects are obviously not super attractive to men, so this is a focal therapy. It was really hot at that time and everybody wanted Wait, wait, wait, wait. 03:22 – Samuel Adeyinka (Host) So why was it hot?